Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,555 | -8,294 | -3,100 | 3,008 | -3,311 |
| Depreciation Amortization | 41 | 81 | 62 | -44 | 40 |
| Other Working Capital | 288 | 1,060 | N/A | N/A | N/A |
| Other Operating Activity | 0 | 1,473 | -1,913 | -211 | 451 |
| Operating Cash Flow | $-6,226 | $-5,680 | $-4,951 | $2,753 | $-2,821 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -30 | N/A | N/A | N/A |
| Other Investing Activity | 14 | 351 | 364 | 5,354 | 4,536 |
| Investing Cash Flow | $9 | $322 | $364 | $5,354 | $4,536 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,383 | 5,033 | 16 | 8,105 | 1,781 |
| Financing Cash Flow | $6,383 | $5,033 | $16 | $8,105 | $1,781 |
| Beginning Cash Position | 1,211 | 1,537 | 264 | 8,107 | 69 |
| End Cash Position | 1,378 | 1,211 | -4,851 | N/A | 1,647 |
| Net Cash Flow | $167 | $-326 | $218 | $16,212 | $4 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,226 | -5,680 | -4,951 | 2,753 | -2,821 |
| Free Cash Flow | -6,226 | -5,680 | -4,951 | 2,753 | -2,821 |